Sign inJoin waitlistJoin the waitlist

KS

Kendra Sweet

Physician · H. Lee Moffitt Cancer Center and Research Institute

Credentials: · · · · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

Hematology and Medical Oncology
2010–2013
Internal Medicine
University of Arizona College of Medicine-Tucson
2007–2010
Doctor of Medicine
2003–2007

Research

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
Journal of Clinical Oncology · 2021 · 429 citations
Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm
New England Journal of Medicine · 2019 · 354 citations
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
Blood · 2021 · 271 citations

JL
Jeffrey Lancet
62 papers
RK
Rami Komrokji
57 papers
DS
David Sallman
51 papers · 1 as a fellow
Eric Padron
50 papers
AK
Andrew Kuykendall
41 papers · 4 as a fellow
OC
Onyee Chan
34 papers · 2 as a fellow
CT
Chetasi Talati
24 papers · 7 as a fellow
Javier Pinilla-Ibarz
17 papers
Somedeb Ball
17 papers · 12 as a fellow
Akriti Jain
16 papers · 12 as a fellow
LZ
Ling Zhang
16 papers
AL
Alan List
15 papers

Clinical trials

Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 2
SWOG Cancer Research Network
2018–2028
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2015–2021
Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2013–2019